• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

Professional Introduction to N2,N2-Dimethyl-3-(trifluoromethyl)pyridine-2,5-diamine (CAS No. 288247-16-5)

N2,N2-Dimethyl-3-(trifluoromethyl)pyridine-2,5-diamine is a highly specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, identified by its CAS number 288247-16-5, is a derivative of pyridine and features a unique structural configuration that makes it particularly valuable for various synthetic applications. The presence of both N,N-dimethylation and a trifluoromethyl group imparts distinct electronic and steric properties, which are crucial for its utility in medicinal chemistry.

The compound's molecular structure consists of a pyridine core with two amino groups at the 2 and 5 positions, further modified by methyl groups at the 2 positions and a trifluoromethyl group at the 3 position. This specific arrangement enhances its reactivity and makes it a versatile intermediate in the synthesis of more complex molecules. The trifluoromethyl group, in particular, is known for its ability to improve metabolic stability and binding affinity in drug candidates, making this compound a promising building block for novel therapeutic agents.

In recent years, there has been growing interest in the development of small-molecule inhibitors targeting various biological pathways. N2,N2-Dimethyl-3-(trifluoromethyl)pyridine-2,5-diamine has emerged as a key intermediate in the synthesis of inhibitors for enzymes involved in cancer metabolism. For instance, studies have demonstrated its utility in generating compounds that modulate the activity of pyruvate kinase M2 (PKM2), an enzyme critical for glycolysis regulation in tumor cells. The incorporation of the trifluoromethyl group into these inhibitors has been shown to enhance their potency and selectivity, leading to more effective pharmacological outcomes.

The compound's application extends beyond oncology; it has also been explored in the development of antimicrobial agents. Researchers have leveraged its structural features to design molecules that interact with bacterial enzymes, disrupting essential metabolic pathways. The combination of N,N-dimethylation and the trifluoromethyl group provides a scaffold that can be easily modified to optimize binding interactions with target proteins. This flexibility has allowed chemists to fine-tune the properties of derived compounds, resulting in enhanced efficacy against resistant strains of bacteria.

The synthesis of N2,N2-Dimethyl-3-(trifluoromethyl)pyridine-2,5-diamine involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions and nucleophilic substitutions, are often employed to construct the desired framework efficiently. The purity of the final product is paramount, as impurities can significantly affect downstream applications. Therefore, rigorous purification protocols, including column chromatography and recrystallization, are typically employed to isolate the compound in high yield and quality.

In terms of pharmacological activity, derivatives of N2,N2-Dimethyl-3-(trifluoromethyl)pyridine-2,5-diamine have shown promise in preclinical studies. For example, modifications at the 4-position of the pyridine ring have led to compounds with inhibitory effects on tyrosine kinases, which are overexpressed in many solid tumors. The electron-withdrawing nature of the trifluoromethyl group enhances the lipophilicity of these derivatives, facilitating their penetration across biological membranes. This property is particularly important for drugs intended to exert their effects intracellularly.

The compound's potential also lies in its role as a chiral building block. By introducing stereocenters into derivatives derived from N2,N2-Dimethyl-3-(trifluoromethyl)pyridine-2,5-diamine, researchers can generate enantiomerically pure compounds with tailored biological activities. Chiral drugs often exhibit different pharmacokinetic profiles compared to their racemic counterparts, making stereochemical control a critical aspect of drug design. The ability to produce enantiomerically enriched derivatives from this intermediate opens up new avenues for developing next-generation therapeutics.

The growing body of research on N2,N2-Dimethyl-3-(trifluoromethyl)pyridine-2,5-diamine underscores its importance as a versatile chemical entity. As computational methods and high-throughput screening technologies advance, the discovery of new applications for this compound is likely to expand further. Collaborative efforts between synthetic chemists and biologists will continue to drive innovation, leveraging its unique structural features to address unmet medical needs.

In conclusion, N2,N2-Dimethyl-3-(trifluoromethyl)pyridine-2,5-diamine (CAS No. 288247-16-5) represents a significant advancement in pharmaceutical chemistry. Its distinctive molecular architecture makes it an invaluable intermediate for synthesizing biologically active molecules with potential applications across multiple therapeutic areas. As research progresses, this compound is expected to play an increasingly pivotal role in the development of novel drugs that improve patient outcomes worldwide.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)